Recent trends in hepatitis B virus infection in the general Korean population

Korean Journal of Internal Medicine

Volumn 28, Issue 4, 2013, Pages 413-419

  Kim, Hyuck ^a   Shin, A Ri ^a   Chung, Hoe Hoon ^a   Kim, Min Kyoung ^a   Lee, Ji Sung ^b   Shim, Jae Jun ^a   Kim, Byung Ho ^a  

^a Kyung Hee University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Age groups; Hepatitis B surface antigens; Hepatitis B virus; Korea; Prevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENCE; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; CHILD; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HEPATITIS B; HUMAN; INCOME; INFECTION RATE; KOREA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERSISTENT VIRUS INFECTION; PREVALENCE; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; SCHOOL CHILD; SELF REPORT; SOCIAL STATUS; TREND STUDY; VACCINATION; VIRUS CARRIER;

AGE GROUPS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; KOREA; PREVALENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84880415941     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2013.28.4.413     Document Type: Article

References (21)

1. Hepatitis B vaccines. Wkly Epidemiol Rec 2009;84:405-419.
2. Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990;8 Suppl:S18-S20.
3. Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children. J Korean Pediatr Soc 1995;38:1535-1539.
4. Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 2000;19:1026-1037.
5. Jang KM, Woo SH, Yun DH, et al. Seroepidemiologic survey on type B viral hepatitis in inchon area, Department of Internal Medicine, Inchon Christian Hospital. Korean J Med 1983;26:1331-1336.
6. Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. N Am J Med Sci (Boston) 2011;4:7-13.
7. Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology 2010;53:20-28.
8. Korea Centers for Disease Control and Prevention. The fifth Korea National Health and Nutrition Examination Survey (KNHANES V-1) [Internet]. Cheongwon: Korea Centers for Disease Control and Prevention, 2010 [cited 2012 May 10]. Available from: http://knhanes.cdc.go.kr.
9. Lin HH, Wang LY, Hu CT, et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003;69:471-474.
10. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-1102.
11. Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54(RR-16):1-31.
12. Ahn YO, Kim CY, Bae SH, Chang HG. Changing pattern of HBV-related diseases in Korea since after HBV vaccination. Korean J Hepatol 2010;16(4 Suppl):S23-S37.
13. Han BS, Kim IS, Suh I. A study of the seroconversion rates of anti HBs and the duration of anti HBS persistence after hepatitis B vaccination. Korean J Epidemiol 1989;11:215-231.
14. Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol 2009;15 Suppl 6:S13-S24.
15. Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44:11-24.
16. Chang MH, Shau WY, Chen CJ, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 2000;284:3040-3042.
17. Hwang SH, Oh HB, Kim HS, Lee EY. Evaluation of HBs Ag, HCV and HIV Ag-Ab assays using Bio-Rad elite microplate analyzer. Korean J Lab Med 2006;26:436-441.
18. Manetta T, Gay V, Spreafico G, Massaro A, Piantino P. Instrument applications of three new Bio-Rad kits for HIV, HCV, HBSAG screening: Combo Genscreen Plus HIV 1/2 AG-AB, Monolisa anti HCV Plus V2, Monolisa HBSAG Plus, with the fully authomatic system Plato 3300. Minerva Med 2001;92:393-400.
19. Louisirirotchanakul S, Khupulsup K, Akraekthalin S, et al. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays. J Med Virol 2010;82:755-762.
20. Louisirirotchanakul S, Kanoksinsombat C, O'Charoen R, et al. HBsAg diagnostic kits in the detection of hepatitis B virus mutation within "a" determinant. Viral Immunol 2006;19:108-114.
21. Xu W, Li Y, Wang M, Gu J. Comparison of two immunoassays for determining hepatitis B virus serum markers. Clin Chem Lab Med 2011;50:153-157.